Central Bank & Trust CO Charles River Laboratories International, Inc. Transaction History

Central Bank & Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 13, 2023	BUY	$191.89 - $259.92 $1,151 - $1,559	6 New	6 $1,000
Q2 2022 Jul 22, 2022	SELL	$204.13 - $302.4 $3.6 Million - $5.33 Million	-17,613 Closed	0 $0
Q1 2022 Apr 18, 2022	BUY	$255.51 - $362.11 $3.19 Million - $4.52 Million	12,484 Added 243.4%	17,613 $5 Million
Q4 2021 Jan 18, 2022	BUY	$351.38 - $448.68 $1.8 Million - $2.3 Million	5,129 New	5,129 $1.93 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Bank & Trust CO with notifications on news.